Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2026American Journal of HematologyOpen Access

Anticoagulant Therapy and Bleeding‐Related Hospitalizations in Patients With Cancer: A National Cohort Study

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does anticoagulant therapy affect bleeding-related hospitalizations in US veterans with cancer?

Population

US veterans with cancer

Design

Cohort

Key result

Anticoagulant therapy in patients with cancer was evaluated for its association with bleeding-related hospitalizations in a national cohort of US veterans.

Authors

AAAmber AfzalLSLuo SuhongAMAmir Mahmoud

Discussion

Loading...

Member takes

Overview

Anticoagulant use may raise bleeding hospitalization risk in cancer veterans; hypothesis-generating and should not yet alter practice pending RCTs.

Key Points

  • To assess rates of bleeding-related hospitalizations associated with anticoagulant therapy among patients diagnosed with cancer.
  • Retrospective cohort study analyzing medical data from a national cohort of US veterans with cancer receiving anticoagulant therapy.
  • Bleeding-related hospitalization rates associated with anticoagulant therapy were measured across the cohort of cancer patients (specific event rates and effect sizes not provided in the abstract).

Structured PICO

Does anticoagulant therapy affect bleeding-related hospitalizations in US veterans with cancer?

P
Population
US veterans with cancer
I
Intervention
Anticoagulant therapy
O
Outcome
Bleeding-related hospitalizationssafety

Cite This Study

Afzal et al. (2026) studied this question. Anticoagulant therapy in patients with cancer was evaluated for its association with bleeding-related hospitalizations in a national cohort of US veterans.

synapsesocial.com/papers/6aa27a9f58559d80afc735b5https://doi.org/10.1002/ajh.70491
View Full Paper
Ask AI
Bookmark
Share